29 completed. 29 Phase 2, 6 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 29 | Completed 29 |
| Phase 1 | 6 | Completed 6 |
| Phase 3 | 2 | Completed 2 |
Follow Medication Adherence: new trials by email Literature Review of Medication Adherence trials Research Report on Medication Adherence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video Observation HiDO-ALZ - Alzheimer Disease, Dementia | Phase 2 | Completed | HiDO Technologies | 50 | 2024-09-05 | 2026-10-07 |
| Heart Failure Polypill at a Safety Net Hospital Heart failure polypill, Control Rx - Heart Failure With Reduced Ejection Fraction, HIV Infections | Phase 2 | Completed | University of California, San Francisco | 35 | 2024-02-27 | 2025-12-31 |
| Project Engage: Oral PrEP Acceptability emtricitabine/tenofovir alafenamide, Emtricitabine / Tenofovir Disoproxil Oral Tablet - Acceptability of Health Care, Adherence, Medication | Phase 2 | Completed | Eastern Virginia Medical School | 330 | 2022-06-21 | 2024-07-29 |
| Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers Maintenance ICS and Symptom Driven SABA, Symptom-driven budesonide/formoterol combination - Asthma in Children, Nonadherence, Medication | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 55 | 2022-04-01 | 2026-08-19 |
| Medication Responsiveness in Parkinson's Disease CloudUPDRS - Tapping Task - Parkinson Disease, Medication Compliance | Phase 2 | Completed | KU Leuven | 33 | 2019-07-25 | 2021-01-27 |
| Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment Polycap - Atherosclerosis, Adherence, Medication | Phase 2 | Completed | Northern California Institute of Research and Education | 148 | 2019-02-14 | 2023-12-20 |
| Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 150 | 2018-02-02 | 2021-05-18 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 26 | 2015-11-02 | 2020-03-10 |
| Directly Observed Therapy for HCV in Chennai, India Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin - Hepatitis C, Chronic | Phase 2 | Completed | Johns Hopkins Bloomberg School of Public Health | 50 | 2015-09-01 | 2021-04-15 |
| Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication. Experimental - Medication Adherence | Phase 2 | Completed | Inflexxion, Inc. | 176 | 2012-09-01 | 2014-05-19 |
| Nurse Delivered Cell Phone Adherence Intervention (Pick It UP) Adherence Counseling, General Health Counseling, Text Messages - Medication Adherence | Phase 1 / Phase 2 | Completed | University of Connecticut | 600 | 2011-07-01 | 2014-12-03 |
| Adaptive Goal-Directed Adherence Tracking and Enhancement AGATE, SASED - Alcohol Abuse | Phase 2 | Completed | Talaria, Inc | 136 | 2011-07-01 | 2014-05-13 |
| Holistic Approaches to Depression Yoga, Healthy Living Workshop - Depression | Phase 2 | Completed | Butler Hospital | 121 | 2011-06-01 | 2016-04-13 |
| Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention Naltrexone, Placebo + Medication Management/Medication Coaching - Reduction in Heavy Drinking in Patients With HIV | Phase 2 / Phase 3 | Completed | Yale University | 51 | 2011-04-01 | 2019-03-21 |
| Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults Medication adherence intervention, Attention-control - Hypercholesterolemia, Medication Adherence | Phase 1 / Phase 2 | Completed | University of Missouri-Columbia | 43 | 2010-10-01 | 2016-10-24 |
| Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia PROTECT DC - Stroke | Phase 2 | Completed | Georgetown University | 230 | 2008-04-01 | 2013-02-21 |
| Health Education vs. Health Education Plus Physical Therapy for Low Back Pain Patients General health talk, Handout of The Back Book, Back exercise - Low Back Pain | Phase 2 | Completed | Kovacs Foundation | 680 | 2007-03-01 | 2009-05-28 |
| A Mindfulness Based Approach to HIV Treatment Side Effects Mindfulness-based Stress Reduction (MBSR) - HIV Infections | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 76 | 2006-07-01 | 2016-05-16 |
| Behavioral Exercise Intervention for Smoking Cessation aerobic exercise, Health Education Control - Nicotine Dependence | Phase 2 | Completed | Butler Hospital | 61 | 2006-04-01 | 2015-01-30 |
| Treatment for Nonspecific Low Back Pain in Primary Care: a Trial on Different Health Education Booklets The Back Book, The Back Guide, General health book - Low Back Pain | Phase 2 | Completed | Kovacs Foundation | 240 | 2005-10-01 | 2014-03-13 |
Showing 20 of 29. Sign in to see all of them.
Health Education (12) · Directly Observed Therapy (4) · HIV Infections (4) · Acquired Immunodeficiency Syndrome (3) · Alcoholism (2) · Atherosclerosis (2) · Depression (2) · Hepatitis C, Chronic (2) · Low Back Pain (2) · Alzheimer Disease (1) · Asthma (1) · Behavior (1) · Colic (1) · Crying (1)
Health Behavior (29) · Patient Compliance (29) · Treatment Adherence and Compliance (29) · Behavior (28) · Patient Acceptance of Health Care (28) · Adherence Interventions (12) · Blood-Borne Infections (7) · Communicable Diseases (7) · Immune System Diseases (7) · Infections (7) · RNA Virus Infections (7) · Virus Diseases (7) · Genital Diseases (5) · Immunologic Deficiency Syndromes (5)
Exercise (2) · Sofosbuvir (2) · peginterferon alfa-2a (2) · Carbon Monoxide (1) · Counseling (1) · Diet Therapy (1) · Emtricitabine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Fluoxetine (1) · Lopinavir (1) · Meditation (1) · Mindfulness-Based Stress Reduction (1) · Naltrexone (1) · Ribavirin (1) · Self-Help Groups (1)
Butler Hospital (2) · Johns Hopkins Bloomberg School of Public Health (2) · Kovacs Foundation (2) · San Diego State University (2) · University of California, San Francisco (2) · Brigham and Women's Hospital (1) · Eastern Virginia Medical School (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Georgetown University (1) · HiDO Technologies (1) · Inflexxion, Inc. (1) · KU Leuven (1) · M.D. Anderson Cancer Center (1) · Massachusetts General Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (20) · India (2) · South Africa (2) · Spain (2) · Belgium (1) · Canada (1) · Ghana (1) · Puerto Rico (1) · Zimbabwe (1)
Alexander Dromerick, MD (1) · Alice Nieuwboer (1) · Ana Abrantes, PhD (1) · Antonio Ruiz, MD (1) · Carlos Isanta, MD (1) · Celia Albaladejo, MD (1) · Charles Flexner, MD (1) · Chelsea S. Kidwell, MD (1) · Christina D Adams, PhD (1) · Colette DeJong, MD (1) · David R. Bangsberg, MD, MPH (1) · Donna Mildvan, MD (1) · Elizabeth Donovan, Ph. D. (1) · Francisco M Kovacs, MD, PhD (1)
PMID 11764222, PMID 19255065, PMID 19597072, PMID 19928484, PMID 20147875, PMID 20192725, PMID 23186301, PMID 23248342, PMID 25909320, PMID 27590273, PMID 28719029, PMID 29540234, PMID 30633744, PMID 31141465, PMID 37268772, PMID 37734804, PMID 39082406, PMID 40118491
R01DA026727 (2), K01CA160670 (1), K23DA019950 (1), KL2TR002346 (1), P60AR036308 (1), R01AA018923 (1), R01AR044020 (1), R01MH063011 (1), R01NR012005 (1), R01NR012962 (1), R21AT003102 (1), U54NS057405 (1), UL1TR002345 (1)